Snowball logo
logo
VRCA_logo

Verrica Pharmaceuticals Inc

VRCA β€’ NASDAQ
$3.42-$0.11Β  (3.12%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
129.0325.1247.56635.5830.32
COGS
0.4720.7250.7462.743.4414.277
Gross Profit
11.538.3074.3784.82632.1426.04
Operating Expenses & Income
Operating Income
(30.91)(21.3)(65.76)(65.92)(11.94)(28.13)
Total Operating Expenses
42.4429.670.1470.7544.0854.17
R&D Expenses
15.9312.220.311.848.85514.62
Selling General & Admin Expenses
26.9817.4147.358.0235.2238.29
Earnings from Continuing Operations
Interest Expense
(4.295)(2.172)(3.962)(9.412)(7.742)(3.732)
Interest Income
0.1230.4762.2341.4170.9290.676
Income Tax Expense
3.8233.1910.668105---
Net Income
Net Income
(35.08)(24.49)(67)(76.58)(17.89)(31.18)
Supplemental
EBIT
(30.79)(22.32)(63.03)(67.17)(10.14)(27.45)
EBITDA
(30.31)(21.6)(62.2)(65.9)(9.363)(26.68)
In millions of USD, except % and values per 1 share